Patients with stage I or II hormone receptor-negative breast cancer do not benefit from preoperative breast MRI, according to ...
The gonadotropin hormone receptors, including the follicle-stimulating hormone receptor (FSHR) and the luteinizing hormone/choriogonadotropin receptor (LH/CGR), serve as integral mediators of ...
Tukysa added to Herceptin and Perjeta improved progression-free survival versus placebo in HER2-positive metastatic breast ...
Is omission of the sentinel lymph node biopsy safe in early breast cancer in patients treated with breast conserving therapy ...
Progesterone Receptor Positive (PR+) breast cancer is a distinct biological subtype of hormone receptor positive breast cancer. This type of cancer grows in response to progesterone, a hormone that is ...
News-Medical.Net on MSN
Next-generation oral SERD therapy lowers the risk of breast cancer recurrence
In an international study led by UCLA, researchers have shown that giredestrant, a next-generation oral selective estrogen ...
Overall response rate (ORR) of 55% and median progression-free survival of 14.5 months in patients without TP53 gene mutationPhase 2 results ...
In a comprehensive review published in the October 2024 issue of Genomic Psychiatry, researchers have unveiled crucial insights into how two types of hormone receptors collaborate to maintain brain ...
For more than 20 years, women entering menopause were told to be afraid of hormone replacement therapy. Headlines warned of ...
Testing for aldosterone levels may hold the key to treatment-resistant hypertension and many other cardiac conditions, but ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback